Glaukos Corporation | Mid-cap | Healthcare

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 383.5M
Gross Profit 289.5M 75.48%
Operating Income -108.1M -28.20%
Net Income -146.4M -38.17%
EPS (Diluted) -$2.77

Balance Sheet Metrics

Total Assets 974.8M
Total Liabilities 207.8M
Shareholders Equity 766.9M
Debt to Equity 0.27

Cash Flow Metrics

Operating Cash Flow -70.3M
Free Cash Flow -67.6M

Revenue & Profitability Trend

Glaukos Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue383.5M314.7M282.9M294.0M225.0M
Cost of Goods Sold94.0M75.6M69.0M66.6M91.7M
Gross Profit289.5M239.1M213.9M227.4M133.2M
Operating Expenses397.6M362.8M316.2M280.3M256.8M
Operating Income-108.1M-123.7M-102.3M-52.9M-123.6M
Pre-tax Income-145.6M-133.7M-98.4M-49.3M-132.3M
Income Tax771.0K934.0K766.0K326.0K-12.0M
Net Income-146.4M-134.7M-99.2M-49.6M-120.3M
EPS (Diluted)-$2.77-$2.78-$2.09-$1.07-$2.70

Income Statement Trend

Glaukos Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets449.8M395.5M443.9M486.1M469.4M
Non-Current Assets525.0M545.0M558.5M563.6M536.1M
Total Assets974.8M940.4M1.0B1.0B1.0B
Liabilities
Current Liabilities75.1M74.0M72.4M63.4M49.7M
Non-Current Liabilities132.7M404.6M400.0M399.2M288.4M
Total Liabilities207.8M478.6M472.4M462.5M338.1M
Equity
Total Shareholders Equity766.9M461.8M530.0M587.2M667.4M

Balance Sheet Composition

Glaukos Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-146.4M-134.7M-99.2M-49.6M-120.3M
Operating Cash Flow-70.3M-56.4M-41.5M12.0M-11.4M
Investing Activities
Capital Expenditures-6.3M-20.2M-30.1M-47.8M-6.9M
Investing Cash Flow47.8M14.1M44.8M-58.2M-205.1M
Financing Activities
Dividends Paid-----
Financing Cash Flow44.8M-4.0M-3.0M8.3M238.3M
Free Cash Flow-67.6M-78.0M-63.3M-23.1M-29.9M

Cash Flow Trend

Glaukos Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -37.81
Forward P/E -93.12
Price to Book 7.61
Price to Sales 14.47
PEG Ratio -93.12

Profitability Ratios

Profit Margin -30.57%
Operating Margin -19.39%
Return on Equity -20.36%
Return on Assets -6.68%

Financial Health

Current Ratio 6.49
Debt to Equity 14.09
Beta 0.81

Per Share Data

EPS (TTM) -$2.27
Book Value per Share $13.46
Revenue per Share $7.42

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
gkos5.9B-37.817.61-20.36%-30.57%14.09
Abbott Laboratories 233.3B17.424.7830.65%31.89%27.09
Boston Scientific 154.3B75.796.919.50%11.58%52.16
Masimo 8.8B129.169.35-25.07%-23.25%72.01
Globus Medical 7.7B42.441.884.63%7.39%2.27
Bio-Rad 7.1B-3.831.03-27.52%-85.16%20.50

Financial data is updated regularly. All figures are in the company's reporting currency.